SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells

Klebsiella pneumoniae has emerged as a major clinical and public health threat owing to the increasing prevalence of healthcare-associated infections caused by multidrug-resistant or extensively drug-resistant strains. However, increasing antibiotic resistance and the absence of clinically effective...

Descripción completa

Detalles Bibliográficos
Autores principales: She, Pengfei, Liu, Yaqian, Xu, Lanlan, Li, Yimin, Li, Zehao, Liu, Shasha, Hussain, Zubair, Wu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971605/
https://www.ncbi.nlm.nih.gov/pubmed/35372124
http://dx.doi.org/10.3389/fcimb.2022.858606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971605/
https://www.ncbi.nlm.nih.gov/pubmed/35372124
http://dx.doi.org/10.3389/fcimb.2022.858606

Ejemplares similares